Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2026-01-07 @ 7:13 AM
Study NCT ID:
NCT05096832
Status:
COMPLETED
Last Update Posted:
2023-04-25
First Post:
2021-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Sponsor:
Livzon Pharmaceutical Group Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TG2102V01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None